ZOETIS INC - CLASS A
Acción · US98978V1035 · ZTS · A1KBYX (XNYS)
170,16 USD
06.06.2025 20:00
Cotizaciones actuales de ZOETIS INC - CLASS A
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NYSE |
ZTS
|
USD
|
06.06.2025 20:00
|
170,16 USD
| 168,61 USD
+0,92 %
|
![]() XETRA |
ZOE.DE
|
EUR
|
06.06.2025 15:35
|
149,54 EUR
| 147,64 EUR
+1,29 %
|
![]() London |
0M3Q.L
|
USD
|
06.06.2025 15:11
|
170,84 USD
| 168,61 USD
+1,32 %
|
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 0,91 % | 13,54 % | 1,74 % | -3,79 % | -3,66 % | 20,67 % |
Firmenprofil zu ZOETIS INC - CLASS A Aktie
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Investierte Fonds
Folgende Fonds haben in investiert: ZOETIS INC - CLASS A investiert:
Fonds | Vol. in Mio 23.675,81 | Anteil (%) 1,35 % |
Fonds | Vol. in Mio 4.499,54 | Anteil (%) 1,31 % |
Fonds | Vol. in Mio 5.304,44 | Anteil (%) 1,31 % |
Fonds | Vol. in Mio 4.623,95 | Anteil (%) 1,27 % |
Fonds | Vol. in Mio 22,09 | Anteil (%) 0,71 % |
Unternehmensdaten
Name ZOETIS INC - CLASS A
Firma Zoetis Inc.
Symbol ZTS
Website
https://www.zoetis.com
Heimatbörse
NYSE

WKN A1KBYX
ISIN US98978V1035
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Ms. Kristin C. Peck
Marktkapitalisierung 59 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 13,8 T
Adresse 10 Sylvan Way, 07054 Parsippany
IPO Datum 2019-11-11
Dividenden von 'ZOETIS INC - CLASS A'
Ex-Datum | Dividende pro Aktie |
---|---|
21.04.2025 | 0,50 USD |
21.01.2025 | 0,50 USD |
31.10.2024 | 0,43 USD |
18.07.2024 | 0,43 USD |
18.04.2024 | 0,43 USD |
18.01.2024 | 0,43 USD |
31.10.2023 | 0,38 USD |
20.07.2023 | 0,38 USD |
20.04.2023 | 0,38 USD |
19.01.2023 | 0,38 USD |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | ZOE.F |
London | 0M3Q.L |
NYSE | ZTS |
XETRA | ZOE.DE |
Weitere Aktien
Investoren die ZOETIS INC - CLASS A die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.